November 19, 2006
Proactive Acne Treatment - Fougera Receives Approval For First Generic Sulfacetamide Sodium Topical Suspension USP 10% (Rx)
Specialty pharmaceutical manufacturer Fougera, a division of ALTANA Inc, announced today that it has received FDA approval to bring to market the first generic Sulfacetamide Sodium Topical Suspension USP 10% (Rx). The generic formulation compares to KLARON(R) by Dermik, whose patent has expired. The market for the brand name product was approximately $25 million in 2005. [click link for full …continued
Shire plc (LSE: SHP, Nasdaq: SHPGY, TSX: SHQ) announced today that a single once-daily morning dose of the investigational amphetamine compound SPD465, extended release triple-bead mixed amphetamine salts, designed to reduce symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in adul [click link for full article] …continued
(Full text of statement. Contact details below.) …continued
Tags: proactive acne treatment, acne treatment, proactive treatment, proactive